Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 16;16(18):2764-2768.
doi: 10.1002/cmdc.202100278. Epub 2021 Jun 10.

Albumin Conjugates of Thiosemicarbazone and Imidazole-2-thione Prochelators: Iron Coordination and Antiproliferative Activity

Affiliations

Albumin Conjugates of Thiosemicarbazone and Imidazole-2-thione Prochelators: Iron Coordination and Antiproliferative Activity

Yu-Shien Sung et al. ChemMedChem. .

Abstract

The central role of iron in tumor progression and metastasis motivates the development of iron-binding approaches in cancer chemotherapy. Disulfide-based prochelators are reductively activated upon cellular uptake to liberate thiol chelators responsible for iron sequestration. Herein, a trimethyl thiosemicarbazone moiety and the imidazole-2-thione heterocycle are incorporated in this prochelator design. Iron binding of the corresponding tridentate chelators leads to the stabilization of a low-spin ferric center in 2 : 1 ligand-to-metal complexes. Native mass spectrometry experiments show that the prochelators form stable disulfide conjugates with bovine serum albumin, thus affording novel bioconjugate prochelator systems. Antiproliferative activities at sub-micromolar levels are recorded in a panel of breast, ovarian and colorectal cancer cells, along with significantly lower activity in normal fibroblasts.

Keywords: albumin; cancer; imidazole-2-thione; iron chelation; thiosemicarbazone.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Structures of reported iron chelators and disulfide-based prochelators.
Figure 2.
Figure 2.
Disulfide-based prochelators characterized in this study.
Figure 3.
Figure 3.
Crystal structures of [Fe(244mTC−H)2]+ (left) and [Fe(IT1−H)2]+ (right) showing a partial atom labeling scheme. Thermal ellipsoids are scaled to the 50% probability level. Carbon-bound hydrogen atoms in calculated positions and [BF4] counter ions are not shown (CCDC, left: 2060902, right: 2060901)
Figure 4.
Figure 4.
EPR spectra of [Fe(244mTC−H)2]+ (top) and [Fe(IT1−H)2]+ (bottom) in frozen DMSO/water solution (70/30%, v/v). The pH of the solution was estimated at 7.0 using colorimetric indicator strips with a sensitivity of 0.5 pH units. Experimental conditions: microwave frequency, 9.4 GHz; microwave power, 2 mW; magnetic field modulation amplitude, 0.2 mT; temperature, 77 K.
Figure 5.
Figure 5.
Covalent modifications of BSA by disulfide prochelators as monitored by native mass spectrometry. Spectra are shown on the left with annotated charge states. Corresponding deconvolved mass distributions are shown on the right. Solutions of BSA (1.0 μM) in aqueous ammonium acetate (0.2 M, pH 6.8) were incubated in the presence of prochelators (244mTC-S)2 (panels a, b), (IT1-S)2 (c, d), (IT2-S)2 (e, f), or control thioether TE1 (g, h). The concentration of all tested compounds was 10 μM, and the incubations were conducted at room temperature for 24 h.

Similar articles

Cited by

References

    1. Torti SV, Torti FM, Cancer Res. 2020, 80, 5435–5448. - PMC - PubMed
    1. Jung M, Mertens C, Tomat E, Brüne B, Int. J. Mol. Sci 2019, 20, 273. - PMC - PubMed
    1. Bauer M, Eickhoff JC, Gould MN, Mundhenke C, Maass N, Friedl A, Breast Cancer Res. Treat 2008, 108, 389–397. - PubMed
    1. Pinnix ZK, Miller LD, Wang W, D’Agostino R, Kute T, Willingham MC, Hatcher H, Tesfay L, Sui G, Di X, Torti SV, Torti FM, Sci. Transl. Med 2010, 2, 43ra56. - PMC - PubMed
    1. Crielaard BJ, Lammers T, Rivella S, Nat. Rev. Drug Discov 2017, 16, 400–423. - PMC - PubMed

MeSH terms

LinkOut - more resources